Gilead Sciences Corporate Bonds

Gilead Sciences financial leverage is the degree to which the firm utilises its fixed-income securities. Companies with high leverage are usually considered to be at financial risk. Gilead Sciences Inc financial risk is the risk to Gilead Sciences stockholders that is caused by an increase in debt. In other words with a high degree of financial leverage come high interest payments which usually reduces Earnings Per Share (EPS). Please also check analysis of Gilead Sciences Fundamentals Over Time

Financial Leverage Over Time

Interest burden is a component of DuPont return on equity analysis calculated by dividing Earnings before Tax by Earning Before Interest and Taxes EBIT . This will be 1 for a company with no Interest Expense.
 Financial Leverage 
      Timeline 

Leverage Ratio Over Time

Leverage Ratio is a measure of a firms financial leverage, calculated by dividing Average Assets by Average Equity. A component of DuPont return on equity analysis.
 Leverage Ratio 
      Timeline 

Gilead Sciences Corporate Bonds Issued

 
Piotroski F Score   
6  Healthy
Issue DateMaturityCouponRef CouponS&P Rating
375558AQ6 4.5% Corp Bond03/30/201104/01/20214.52.0
A-
375558AR4 2.4% Corp Bond12/13/201112/01/20142.40.0
A-
375558AS2 5.65% Corp Bond12/13/201112/01/20415.653.0
A-
375558AT0 3.05% Corp Bond12/13/201112/01/20163.050.375
A-
375558AU7 4.4% Corp Bond12/13/201112/01/20214.42.0
A-
375558AV5 2.05% Corp Bond03/07/201404/01/20192.051.5
A-
375558AW3 3.7% Corp Bond03/07/201404/01/20243.72.25
A-
375558AX1 4.8% Corp Bond03/07/201404/01/20444.83.0
A-
375558AY9 2.35% Corp Bond11/17/201402/01/20202.351.5
A-
375558AZ6 3.5% Corp Bond11/17/201402/01/20253.52.25
A-
375558BA0 4.5% Corp Bond11/17/201402/01/20454.53.0
A-
Very Good
Total Macroaxis Rating
 
A-
Average S&P Rating

Gilead Sciences Debt Analysis

The company currently holds 26.32 B in liabilities with Debt to Equity (D/E) ratio of 125.8 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Gilead Sciences Inc has Current Ratio of 2.54 suggesting that it is liquid enough and is able to pay its financial obligations when they are due.

Current Liquidity

Debt to Cash Allocation

Debt

Gilead Sciences Debt Growth Rates

Total Debt

Debt Current